Colorectal Cancer News From Medical News Today
Fri, 05 Dec 2008 10:16:45 +0100
Relevance Of Computer-Aided Detection (CAD) And Image Analysis Software In Early Colon Cancer Screening And Diagnosis
Medicsight PLC, an industry leader in and principal developer of Computer-Aided Detection (CAD) and medical image analysis software today announced clinical results from a new study that demonstrated CAD significantly increased the sensitivity of readers in the detection of colorectal cancers in multi-row detector CT (MDCT) colonography (CTC).
Thu, 04 Dec 2008 01:00:00 PST
Survival Rates In Advanced Rectal Cancer Patients May Be Improved By Preoperative Radiation
Patients treated with radiation prior to surgery for advanced rectal cancer have fewer instances of cancer recurrence and better overall survival rates, according to a recent Geisinger report. The report examined a treatment called neoadjuvant therapy, which can reduce cancerous tumor size or limit the spread of cancer, before surgery to remove the tumor. Neoadjuvant therapy may include chemotherapy and/or radiation.
Wed, 03 Dec 2008 07:00:00 PST
1-Stop Screening For Cancer And Osteoporosis
New research reveals that computed tomography (CT) colonography, also known as virtual colonoscopy, has the potential to screen for two diseases at once - colorectal cancer and osteoporosis, both of which commonly affect adults over age 50. Results of the study will be presented today at the annual meeting of the Radiological Society of North America (RSNA).
Wed, 03 Dec 2008 06:00:00 PST
DxS And Amgen Enter Into Collaboration To Provide A K-RAS Companion Diagnostic For Vectibix(R) In The United States
DxS, a personalised medicine company, has signed an agreement with Amgen Inc. to provide a K-RAS companion diagnostic for Vectibix® (panitumumab) in the United States.
Tue, 02 Dec 2008 05:00:00 PST
Combining Targeted Therapy Drugs May Treat Previously Resistant Tumors
A team of cancer researchers from several Boston academic medical centers has discovered a potential treatment for a group of tumors that have resisted previous targeted therapy approaches.
Mon, 01 Dec 2008 03:00:00 PST
Drop In Colorectal Cancer Deaths
The American Society for Gastrointestinal Endoscopy (ASGE) heralds the recent news of a decline in U.S. cancer deaths and incidence rates, with colorectal cancer among the top three cancers with significant declines. ASGE, representing the specialists in colorectal cancer screening, is excited by the report showing that colorectal cancer deaths among men and women dropped 4.3 percent per year between 2002 and 2005.
Sun, 30 Nov 2008 00:00:00 PST
New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
Simbionix USA Corp, an international company using leading edge simulation to advance clinical performance, announces the world-wide release of a breakthrough training simulation of the laparoscopic colorectal procedure.
Thu, 27 Nov 2008 00:00:00 PST
News From The Journal Of The National Cancer Institute, Nov. 25
No Association Between Fat, Protein, and Meat Consumption and Kidney Cancer There is no association between consumption of fat, protein, or meat and kidney cancer, according to a pooled analysis of prospective studies. The incidence of renal cell cancer is increasing worldwide, but the cause of the increase remains obscure.
Wed, 26 Nov 2008 02:00:00 PST
Genomic Signature Of Colon Cancer May Individualize Treatment
Researchers in the Duke Institute for Genome Sciences & Policy have developed a model for predicting risk of recurrence in early stage colon cancer patients, and have used the model to also predict sensitivity to chemotherapy and targeted therapy regimens. "These findings have important implications for individualizing therapy," said Katherine Garman, M.D., a gastroenterology fellow at Duke and lead investigator on the study.
Tue, 25 Nov 2008 04:00:00 PST
Double-Balloon Enteroscopy Identified As Cost-Effective Approach For Obscure GI Bleeding
A cost-effectiveness analysis conducted by researchers at Stanford University Hospital in Calif., shows that an initial double-balloon enteroscopy (DBE) is a cost-effective approach for patients with obscure gastrointestinal (GI) bleeding.
Tue, 25 Nov 2008 04:00:00 PST
|